A detailed history of Ubs Group Ag transactions in 908 Devices Inc. stock. As of the latest transaction made, Ubs Group Ag holds 8,649 shares of MASS stock, worth $17,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,649
Previous 9,975 13.29%
Holding current value
$17,470
Previous $51,000 41.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.45 - $6.17 $4,574 - $8,181
-1,326 Reduced 13.29%
8,649 $30,000
Q2 2024

Aug 13, 2024

SELL
$5.0 - $7.24 $52,255 - $75,665
-10,451 Reduced 51.17%
9,975 $51,000
Q1 2024

May 13, 2024

SELL
$6.55 - $9.92 $15,182 - $22,994
-2,318 Reduced 10.19%
20,426 $154,000
Q4 2023

Feb 09, 2024

BUY
$4.96 - $12.41 $51,038 - $127,698
10,290 Added 82.62%
22,744 $255,000
Q3 2023

Nov 09, 2023

SELL
$6.0 - $8.2 $27,558 - $37,662
-4,593 Reduced 26.94%
12,454 $82,000
Q2 2023

Aug 11, 2023

BUY
$5.78 - $10.02 $11,739 - $20,350
2,031 Added 13.53%
17,047 $116,000
Q1 2023

May 12, 2023

BUY
$6.61 - $10.66 $71,368 - $115,096
10,797 Added 255.91%
15,016 $129,000
Q4 2022

Feb 08, 2023

BUY
$7.0 - $17.96 $12,460 - $31,968
1,780 Added 72.98%
4,219 $32,000
Q3 2022

Nov 10, 2022

BUY
$15.18 - $24.99 $23,362 - $38,459
1,539 Added 171.0%
2,439 $40,000
Q2 2022

Aug 10, 2022

SELL
$13.3 - $20.74 $15,148 - $23,622
-1,139 Reduced 55.86%
900 $19,000
Q1 2022

May 16, 2022

SELL
$13.18 - $26.28 $122,020 - $243,300
-9,258 Reduced 81.95%
2,039 $39,000
Q4 2021

Feb 14, 2022

BUY
$23.17 - $38.77 $197,547 - $330,553
8,526 Added 307.69%
11,297 $292,000
Q3 2021

Nov 15, 2021

SELL
$29.99 - $39.13 $20,303 - $26,491
-677 Reduced 19.63%
2,771 $90,000
Q2 2021

Aug 13, 2021

BUY
$36.7 - $55.11 $39,085 - $58,692
1,065 Added 44.69%
3,448 $134,000
Q1 2021

May 12, 2021

BUY
$39.94 - $75.0 $95,177 - $178,725
2,383 New
2,383 $116,000

Others Institutions Holding MASS

About 908 Devices Inc.


  • Ticker MASS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,590,200
  • Market Cap $63.8M
  • Description
  • 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...
More about MASS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.